Oct
09

WHO New Guidelines for Alternative Mass Drug Administration Regimens for Lymphatic Filariasis

WHO New Guidelines for Alternative Mass Drug Administration Regimens for Lymphatic Filariasis

Jul
18

Accelerated Clinical Trial Agreement Announcement

SPRI is pleased to announce that we are now part of the Accelerated Clinical Trial Agreement program (ACTA). This allows us to significantly reduce contract negotiation time and get your project up and running faster.

Jul
11

July 2017

150th subject (75% complete) enrolled in the Advanced Parkinson’s Post Marketing Study as of 07 July. On schedule to meet enrollment by the end of 2017. Congratulations to the 52 active sites across 10 countries!

May
01

May 2017

Enrollment completed for all cohorts in a Proof of Concept Open-label, Dose-Escalation Study in subjects with Mild to Moderate Ulcerative Proctitis (UP) or Ulcerative Proctosigmoiditis (UPS). Congratulations to our Georgian sites!

Page: